Jean‐Eric Charoin

The effects of CYP3A4 inhibition on erlotinib pharmacokinetics: computer-based simulation (SimCYP™) predicts in vivo metabolic inhibition

Ashok Rakhit, Michael Pantze, Scott Fettner et al. · European Journal of Clinical Pharmacology · 2007 · 122 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Models and Machines: How Deep Learning Will Take Clinical Pharmacology to the Next Level

Lucy Hutchinson, Bernhard Steiert, Antoine Soubret et al. · CPT Pharmacometrics & Systems Pharmacology · 2018 · 51 citations · Full text

Computing, Pharmacology, Drug Discovery +8

Rituximab Exhibits a Long Half-Life Based on a Population Pharmacokinetic Analysis in Non-Hodgkin’s Lymphoma (NHL) Patients.

Jing Li, Micha Levi, Jean‐Eric Charoin et al. · Blood · 2007 · 29 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Assessment of the bioequivalence of two nelfinavir tablet formulations under fed and fasted conditions in healthy subjects

Benoite Kaeser, Jean‐Eric Charoin, Marianne Gerber et al. · International Journal of Clinical Pharmacology and Therapeutics · 2005 · 24 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

Population Pharmacokinetic/Pharmacodynamic Model for C.E.R.A. in Both ESA‐Naïve and ESA‐Treated Chronic Kidney Disease Patients With Renal Anemia

Pascal Chanu, Ronald Gieschke, Jean‐Eric Charoin et al. · The Journal of Clinical Pharmacology · 2010 · 22 citations

Pharmacy, Pharmacokinetics, Pharmacology +17